The Pathogenesis of Hashimoto's Thyroiditis: Further Developments in our Understanding

Hormone and Metabolic Research

Volumn 47, Issue 10, 2015, Pages 702-710

  Ajjan, R A ^a   Weetman, A P ^b,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

autoimmune hypothyroidism; environmental factors; immunogenetics; immunopathogenesis; thyroid autoantibodies

Indexed keywords

DNA FRAGMENT; IMMUNOGLOBULIN SUBCLASS; INTERLEUKIN 14; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; MICRORNA; PENDRIN; SODIUM IODIDE SYMPORTER; THYROID ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE; THYROTROPIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CELL DEATH; CELL FUNCTION; CELL VIABILITY; CELLULAR IMMUNITY; CLIMATE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; CYTOTOXICITY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; EXISTENTIALISM; GENE ACTIVITY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HASHIMOTO DISEASE; HELPER CELL; HEREDITY; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INCIDENCE; LYMPHOCYTIC INFILTRATION; MANAGED CARE; META ANALYSIS (TOPIC); MICROCHIMERISM; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STRESS; SUPPRESSOR CELL; SYSTEMATIC REVIEW (TOPIC); T LYMPHOCYTE; THYROID FOLLICLE CELL; ENVIRONMENT; GENETICS; IMMUNOLOGY; METABOLISM;

CYTOKINES; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HASHIMOTO DISEASE; HUMANS; IMMUNITY, HUMORAL; MICRORNAS;

EID: 84941553079     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0035-1548832     Document Type: Article

References (112)

1. Hashimoto H. Zur Kenntniss der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Arch Lin Chir: 1912; 97 219 248
2. Doniach D., Hudson R. V. Lymphadenoid goitre (Hashimoto's disease); diagnostic and biochemical aspects. Br Med J: 1957; 1 672 678
3. Carle A., Pedersen I. B., Knudsen N., Perrild H., Ovesen L., Jorgensen T., Laurberg P. Thyroid volume in hypothyroidism due to autoimmune disease follows a unimodal distribution: evidence against primary thyroid atrophy and autoimmune thyroiditis being distinct diseases. J Clin Endocrinol Metab: 2009; 94 833 839
4. Hiromatsu Y., Satoh H., Amino N. Hashimoto's thyroiditis: history and future outlook. Hormones (Athens): 2013; 12 12 18
5. Weetman A. P. The immunopathogenesis of chronic autoimmune thyroiditis one century after hashimoto. Eur Thyroid J: 2013; 1 243 250
6. Caturegli P., De R. A., Rose N. R. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev: 2014; 13 391 397
7. Effraimidis G., Wiersinga W. M. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol: 2014; 170 R241 R252
8. McLeod D. S., Caturegli P., Cooper D. S., Matos P. G., Hutfless S. Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel. JAMA: 2014; 311 1563 1565
9. Wiebolt J., Achterbergh R., den B. A., van der Leij S., Marsch E., Suelmann B., de V. R., van Haeften T. W. Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients. Eur J Endocrinol: 2011; 164 789 794
10. Hou X., Li Y., Li J., Wang W., Fan C., Wang H., Zhang H., Shan Z., Teng W. Development of thyroid dysfunction and autoantibodies in Graves' multiplex families: an eight-year follow-up study in Chinese Han pedigrees. Thyroid: 2011; 21 1353 1358
11. Brix T. H., Hegedus L., Gardas A., Banga J. P., Nielsen C. H. Monozygotic twin pairs discordant for Hashimoto's thyroiditis share a high proportion of thyroid peroxidase autoantibodies to the immunodominant region A. Further evidence for genetic transmission of epitopic fingerprints Autoimmunity: 2011; 44 188 194
12. Outschoorn I. M., Talor M. V., Burek C. L., Hoffman W. H., Rose N. R. Heritability analysis of IgG4 antibodies in autoimmune thyroid disease. Autoimmunity: 2014; 47 320 326
13. Huang C. Y., Chang T. Y., Chu C. C., Lo F. S., Ting W. H., Lin C. H., Wu Y. L., Chu S. Y., Chang S. C., Chen W. F., Lin C. L., Lin W. S., Lee Y. J. The HLA-B gene and Hashimoto disease in Han Chinese children: a case-control and family-based study. Tissue Antigens: 2012; 80 431 436
14. Ueda S., Oryoji D., Yamamoto K., Noh J. Y., Okamura K., Noda M., Kashiwase K., Kosuga Y., Sekiya K., Inoue K., Yamada H., Oyamada A., Nishimura Y., Yoshikai Y., Ito K., Sasazuki T. Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis. J Clin Endocrinol Metab: 2014; 99 E379 E383
15. Bernecker C., Ostapczuk M., Vordenbaumen S., Ehlers M., Thiel A., Schinner S., Willenberg H., Scherbaum W. A., Schott M. HLA-A2 phenotype may be protective against Graves' disease but not against Hashimoto's thyroiditis in Caucasians. Horm Metab Res: 2013; 45 74 77
16. Ji R., Feng Y., Zhan W. W. Updated analysis of studies on the cytotoxic T-lymphocyte-associated antigen-4 gene A49G polymorphism and Hashimoto's thyroiditis risk. Genet Mol Res: 2013; 12 1421 1430
17. Luo L., Cai B., Liu F., Hu X., Wang L. Association of Protein Tyrosine Phosphatase Nonreceptor 22 (PTPN22) C1858T gene polymorphism with susceptibility to autoimmune thyroid diseases: a meta-analysis. Endocr J: 2012; 59 439 445
18. Li M., Sun H., Liu S., Yu J., Li Q., Liu P., Shen H., Sun D. CD40 C/T-1 polymorphism plays different roles in Graves' disease and Hashimoto's thyroiditis: a meta-analysis. Endocr J: 2012; 59 1041 1050
19. Zaaber I., Mestiri S., Marmouch H., Mahjoub S., Abid N., Hassine M., Bel H. Jr, Said K. Polymorphisms in TSHR and IL1RN genes and the risk and prognosis of Hashimoto's thyroiditis. Autoimmunity: 2014; 47 113 118
20. Yan N., Yu Y. L., Yang J., Qin Q., Zhu Y. F., Wang X., Song R. H., Zhang J. A. Association of interleukin-17A and -17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases. Autoimmunity: 2012; 45 533 539
21. Walsh J. P., Berry J., Liu S., Panicker V., Dayan C. M., Brix T. H., Hegedus L., Hou P., Shi B., Morahan G. The clinical presentation of autoimmune thyroid disease in men is associated with IL12B genotype. Clin Endocrinol (Oxf): 2011; 74 508 512
22. Inoue N., Watanabe M., Morita M., Tatusmi K., Hidaka Y., Akamizu T., Iwatani Y. Association of functional polymorphisms in promoter regions of IL5, IL6 and IL13 genes with development and prognosis of autoimmune thyroid diseases. Clin Exp Immunol: 2011; 163 318 323
23. Tomizawa R., Watanabe M., Inoue N., Takemura K., Hidaka Y., Akamizu T., Hayakawa K., Iwatani Y. Association of functional GITR gene polymorphisms related to expression of glucocorticoid-induced tumour necrosis factor-receptor (GITR) molecules with prognosis of autoimmune thyroid disease. Clin Exp Immunol: 2011; 165 141 147
24. Xiao L., Muhali F. S., Cai T. T., Song R. H., Hu R., Shi X. H., Jiang W. J., Li D. F., He S. T., Xu J., Zhang J. A. Association of single-nucleotide polymorphisms in the STAT3 gene with autoimmune thyroid disease in Chinese individuals. Funct Integr Genomics: 2013; 13 455 461
25. Ban Y., Tozaki T., Taniyama M., Skrabanek L., Nakano Y., Ban Y., Hirano T. Multiple SNPs in intron 41 of thyroglobulin gene are associated with autoimmune thyroid disease in the Japanese population. PLoS One: 2012; 7 e37501
26. Stefan M., Jacobson E. M., Huber A. K., Greenberg D. A., Li C. W., Skrabanek L., Conception E., Fadlalla M., Ho K., Tomer Y. Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism. J Biol Chem: 2011; 286 31168 31179
27. Santos L. R., Duraes C., Mendes A., Prazeres H., Alvelos M. I., Moreira C. S., Canedo P., Esteves C., Neves C., Carvalho D., Sobrinho-Simoes M., Soares P. A polymorphism in the promoter region of the selenoprotein S gene (SEPS1) contributes to Hashimoto's thyroiditis susceptibility. J Clin Endocrinol Metab: 2014; 99 E719 E723
28. Simmonds M. J. GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. Nat Rev Endocrinol: 2013; 9 277 287
29. Medici M., Porcu E., Pistis G., Teumer A., Brown S. J., Jensen R. A., Rawal R., Roef G. L., Plantinga T. S., Vermeulen S. H., Lahti J., Simmonds M. J., Husemoen L. L., Freathy R. M., Shields B. M., Pietzner D., Nagy R., Broer L., Chaker L., Korevaar T. I., Plia M. G., Sala C., Volker U., Richards J. B., Sweep F. C., Gieger C., Corre T., Kajantie E., Thuesen B., Taes Y. E., Visser W. E., Hattersley A. T., Kratzsch J., Hamilton A., Li W., Homuth G., Lobina M., Mariotti S., Soranzo N., Cocca M., Nauck M., Spielhagen C., Ross A., Arnold A., van de Bunt M., Liyanarachchi S., Heier M., Grabe H. J., Masciullo C., Galesloot T. E., Lim E. M., Reischl E., Leedman P. J., Lai S., Delitala A., Bremner A. P., Philips D. I., Beilby J. P., Mulas A., Vocale M., Abecasis G., Forsen T., James A., Widen E., Hui J., Prokisch H., Rietzschel E. E., Palotie A., Feddema P., Fletcher S. J., Schramm K., Rotter J. I., Kluttig A., Radke D., Traglia M., Surdulescu G. L., He H., Franklyn J. A., Tiller D., Vaidya B., de M.T., Jorgensen T., Eriksson J. G., O'Leary P. C., Wichmann E., Hermus A. R., Psaty B. M., Ittermann T., Hofman A., Bosi E., Schlessinger D., Wallaschofski H., Pirastu N., Aulchenko Y. S., de la Chapelle A., Netea-Maier R. T., Gough S. C., Meyer Zu S. H., Frayling T. M., Kaufman J. M., Linneberg A., Raikkonen K., Smit J. W., Kiemeney L. A., Rivadeneira F., Uitterlinden A. G., Walsh J. P., Meisinger C., den H. M., Visser T. J., Spector T. D., Wilson S. G., Volzke H., Cappola A., Toniolo D., Sanna S., Naitza S., Peeters R. P. Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease. PLoS Genet: 2014; 10 e1004123
30. Cooper J. D., Simmonds M. J., Walker N. M., Burren O., Brand O. J., Guo H., Wallace C., Stevens H., Coleman G., Franklyn J. A., Todd J. A., Gough S. C. Seven newly identified loci for autoimmune thyroid disease. Hum Mol Genet: 2012; 21 5202 5208
31. Tomer Y., Hasham A., Davies T. F., Stefan M., Concepcion E., Keddache M., Greenberg D. A. Fine mapping of loci linked to autoimmune thyroid disease identifies novel susceptibility genes. J Clin Endocrinol Metab: 2013; 98 E144 E152
32. Caturegli P., De R. A., Chuang K., Dembele M., Iwama A., Iwama S. Hashimoto's thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records. Thyroid: 2013; 23 142 150
33. Ott J., Meusel M., Schultheis A., Promberger R., Pallikunnel S. J., Neuhold N., Hermann M. The incidence of lymphocytic thyroid infiltration and Hashimoto's thyroiditis increased in patients operated for benign goiter over a 31-year period. Virchows Arch: 2011; 459 277 281
34. Kondrashova A., Seiskari T., Ilonen J., Knip M., Hyoty H. The Hygiene 'hypothesis' and the sharp gradient in the incidence of autoimmune and allergic diseases between Russian Karelia and Finland. APMIS: 2013; 121 478 493
35. Aghini L. F., Fiore E., Tonacchera M., Antonangeli L., Rago T., Frigeri M., Provenzale A. M., Montanelli L., Grasso L., Pinchera A., Vitti P. The effect of voluntary iodine prophylaxis in a small rural community: the Pescopagano survey 15 years later. J Clin Endocrinol Metab: 2013; 98 1031 1039
36. Toulis K. A., Anastasilakis A. D., Tzellos T. G., Goulis D. G., Kouvelas D. Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis. Thyroid: 2010; 20 1163 1173
37. van Zuuren E. J., Albusta A. Y., Fedorowicz Z., Carter B., Pijl H. Selenium Supplementation for Hashimoto's Thyroiditis: Summary of a Cochrane Systematic Review. Eur Thyroid J: 2014; 3 25 31
38. Winther K. H., Watt T., Bjorner J. B., Cramon P., Feldt-Rasmussen U., Gluud C., Gram J., Groenvold M., Hegedüs L., Knudsen N., Rasmussen ÅK, Bonnema S. J. The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial. Trials: 2014; 15 115 126
39. Tamer G., Arik S., Tamer I., Coksert D. Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid: 2011; 21 891 896
40. D'Aurizio F., Villalta D., Metus P., Doretto P., Tozzoli R. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun Rev: 2014; Oct 12. pii: S1568-9972(14)00220-1 10.1016/j.autrev.2014.10.008 [Epub ahead of print]
41. Torino F., Barnabei A., Paragliola R., Baldelli R., Appetecchia M., Corsello S. M. Thyroid dysfunction as an unintended side effect of anticancer drugs. Thyroid: 2013; 23 1345 1366
42. Hasham A., Zhang W., Lotay V., Haggerty S., Stefan M., Concepcion E., Dieterich D. T., Tomer Y. Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways. J Autoimmun: 2013; 44 61 70
43. Weetman A. Immune reconstitution syndrome and the thyroid. Best Pract Res Clin Endocrinol Metab: 2009; 23 693 702
44. Daniels G. H., Vladic A., Brinar V., Zavalishin I., Valente W., Oyuela P., Palmer J., Margolin D. H., Hollenstein J. Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis. J Clin Endocrinol Metab: 2014; 99 80 89
45. Visser R., de M. Q., Netea-Maier R. T., van der Ven A. J. Hashimoto's thyroiditis presenting as acute painful thyroiditis and as a manifestation of an immune reconstitution inflammatory syndrome in a human immunodeficiency virus-seropositive patient. Thyroid: 2012; 22 853 855
46. Carle A., Bulow P. I., Knudsen N., Perrild H., Ovesen L., Banke R. L., Jorgensen T., Laurberg P. Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism - a population-based, case-control study. Clin Endocrinol (Oxf): 2012; 77 764 772
47. Effraimidis G., Strieder T. G., Tijssen J. G., Wiersinga W. M. Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. Eur J Endocrinol: 2011; 164 107 113
48. Carle A., Pedersen I. B., Knudsen N., Perrild H., Ovesen L., Rasmussen L. B., Jorgensen T., Laurberg P. Moderate alcohol consumption may protect against overt autoimmune hypothyroidism: a population-based case-control study. Eur J Endocrinol: 2012; 167 483 490
49. Effraimidis G., Tijssen J. G., Wiersinga W. M. Alcohol consumption as a risk factor for autoimmune thyroid disease: a prospective study. Eur Thyroid J: 2012; 1 99 104
50. Caselli E., Zatelli M. C., Rizzo R., Benedetti S., Martorelli D., Trasforini G., Cassai E., degli Uberti E. C., Di L. D., Dolcetti R. Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis. PLoS Pathog: 2012; 8 e1002951
51. Effraimidis G., Tijssen J. G., Strieder T. G., Wiersinga W. M. No causal relationship between Yersinia enterocolitica infection and autoimmune thyroid disease: evidence from a prospective study. Clin Exp Immunol: 2011; 165 38 43
52. Goldner W. S., Sandler D. P., Yu F., Hoppin J. A., Kamel F., Levan T. D. Pesticide use and thyroid disease among women in the Agricultural Health Study. Am J Epidemiol: 2010; 171 455 464
53. de Freitas C. U., Grimaldi Campos R. A., Rodrigues Silva M. A., Panachao M. R., de Moraes J. C., Waissmann W., Roberto C. A., Maeda M. Y., Minazzi Rodrigues R. S., Goncalves B. J., Oliveira B. S., Santos R. T. Can living in the surroundings of a petrochemical complex be a risk factor for autoimmune thyroid disease? Environ Res: 2010; 110 112 117
54. Lee T. P., Chiang B. L. Sex differences in spontaneous versus induced animal models of autoimmunity. Autoimmun Rev: 2012; 11 A422 A429
55. Brix T. H., Hansen P. S., Kyvik K. O., Hegedüs L. Aggregation of thyroid autoantibodies in twins from opposite-sex pairs suggests that microchimerism may play a role in the early stages of thyroid autoimmunity. J Clin Endocrinol Metab: 2009; 94 4439 4443
56. Simmonds M. J., Kavvoura F. K., Brand O. J., Newby P. R., Jackson L. E., Hargreaves C. E., Franklyn J. A., Gough S. C. Skewed X chromosome inactivation and female preponderance in autoimmune thyroid disease: an association study and meta-analysis. J Clin Endocrinol Metab: 2014; 99 E127 E131
57. Lepez T., Vandewoestyne M., Hussain S., Van N. F., Poppe K., Velkeniers B., Kaufman J. M., Deforce D. Fetal microchimeric cells in blood of women with an autoimmune thyroid disease. PLoS One: 2011; 6 e29646
58. Greer L. G., Casey B. M., Halvorson L. M., Spong C. Y., McIntire D. D., Cunningham F. G. Antithyroid antibodies and parity: further evidence for microchimerism in autoimmune thyroid disease. Am J Obstet Gynecol: 2011; 205 471 474
59. Jorgensen K. T., Pedersen B. V., Nielsen N. M., Jacobsen S., Frisch M. Childbirths and risk of female predominant and other autoimmune diseases in a population-based Danish cohort. J Autoimmun: 2012; 38 J81 J87
60. Weetman A. P. Immunity, thyroid function and pregnancy: molecular mechanisms. Nat Rev Endocrinol: 2010; 6 311 318
61. Effraimidis G., Tijssen J. G., Brosschot J. F., Wiersinga W. M. Involvement of stress in the pathogenesis of autoimmune thyroid disease: a prospective study. Psychoneuroendocrinology: 2012; 37 1191 1198
62. Hamilton A., Newby P. R., Carr-Smith J. D., Disanto G., Allahabadia A., Armitage M., Brix T. H., Chatterjee K., Connell J. M., Hegedus L., Hunt P. J., Lazarus J. H., Pearce S. H., Robinson B. G., Taylor J. C., Vaidya B., Wass J. A., Wiersinga W. M., Weetman A. P., Ramagopalan S. V., Franklyn J. A., Gough S. C., Simmonds M. J. Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and Europe. J Clin Endocrinol Metab: 2014; 99 E1459 E1465
63. Cepon T. J., Snodgrass J. J., Leonard W. R., Tarskaia L. A., Klimova T. M., Fedorova V. I., Baltakhinova M. E., Krivoshapkin V. G. Circumpolar adaptation, social change, and the development of autoimmune thyroid disorders among the Yakut (Sakha) of Siberia. Am J Hum Biol: 2011; 23 703 709
64. Volpe R. Suppressor T lymphocyte dysfunction is important in the pathogenesis of autoimmune thyroid disease: a perspective. Thyroid: 1993; 3 345 352
65. MacDonald T. T. Suppressor T cells, rebranded as regulatory T cells, emerge from the wilderness bearing surface markers. Gut: 2002; 51 311 312
66. Fehervari Z., Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest: 2004; 114 1209 1217
67. Piccirillo C. A. Regulatory T cells in health and disease. Cytokine: 2008; 43 395 401
68. Tang Q., Bluestone J. A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol: 2008; 9 239 244
69. Shevach E. M. Suppressor T cells: Rebirth, function and homeostasis. Curr Biol: 2000; 10 R572 R575
70. Pan D., Shin Y. H., Gopalakrishnan G., Hennessey J., De Groot L. J. Regulatory T cells in Graves' disease. Clin Endocrinol (Oxf): 2009; 71 587 593
71. Wang H., Zhao S., Tang X., Li J., Zou P. Changes of regulatory T cells in Graves' disease. J Huazhong Univ Sci Technolog Med Sci: 2006; 26 545 547
72. Marazuela M., Garcia-Lopez M. A., Figueroa-Vega N., de la Fuente H., Alvarado-Sanchez B., Monsivais-Urenda A., Sanchez-Madrid F., Gonzalez-Amaro R. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab: 2006; 91 3639 3646
73. Mao C., Wang S., Xiao Y., Xu J., Jiang Q., Jin M., Jiang X., Guo H., Ning G., Zhang Y. Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease. J Immunol: 2011; 186 4734 4743
74. Glick A. B., Wodzinski A., Fu P., Levine A. D., Wald D. N. Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid: 2013; 23 871 878
75. Mirandola P., Gobbi G., Masselli E., Micheloni C., Di M. D., Queirolo V., Chiodera P., Meschi T., Vitale M. Protein kinase Cepsilon regulates proliferation and cell sensitivity to TGF-1beta of CD4+ T lymphocytes: implications for Hashimoto thyroiditis. J Immunol: 2011; 187 4721 4732
76. Spolski R., Leonard W. J. IL-21 and T follicular helper cells. Int Immunol: 2010; 22 7 12
77. Zhu C., Ma J., Liu Y., Tong J., Tian J., Chen J., Tang X., Xu H., Lu L., Wang S. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab: 2012; 97 943 950
78. Ehlers M., Thiel A., Bernecker C., Porwol D., Papewalis C., Willenberg H. S., Schinner S., Hautzel H., Scherbaum W. A., Schott M. Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto's thyroiditis. J Clin Endocrinol Metab: 2012; 97 1347 1354
79. Wong C. P., Stevens R., Long B., Li L., Wang Y., Wallet M. A., Goudy K. S., Frelinger J. A., Tisch R. Identical beta cell-specific CD8(+) T cell clonotypes typically reside in both peripheral blood lymphocyte and pancreatic islets. J Immunol: 2007; 178 1388 1395
80. Kotani T., Aratake Y., Hirai K., Fukazawa Y., Sato H., Ohtaki S. Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis. Autoimmunity: 1995; 20 231 236
81. Baker J. R. Jr. Dying (apoptosing?) for a consensus on the Fas death pathway in the thyroid. J Clin Endocrinol Metab: 1999; 84 2593 2595
82. Kaczmarek E., Lacka K., Jarmolowska-Jurczyszyn D., Sidor A., Majewski P. Changes of B and T lymphocytes and selected apopotosis markers in Hashimoto's thyroiditis. J Clin Pathol: 2011; 64 626 630
83. Marique L., Van R. V., Gerard A. C., Craps J., Senou M., Marbaix E., Rahier J., Daumerie C., Mourad M., Lengele B., Colin I. M., Many M. C. The expression of dual oxidase, thyroid peroxidase, and caveolin-1 differs according to the type of immune response (TH1/TH2) involved in thyroid autoimmune disorders. J Clin Endocrinol Metab: 2014; 99 1722 1732
84. Weetman A. P. Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol (Oxf): 2004; 61 405 413
85. Walsh J. P., Bremner A. P., Feddema P., Leedman P. J., Brown S. J., O'Leary P. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab: 2010; 95 1095 1104
86. Hamano H., Kawa S., Horiuchi A., Unno H., Furuya N., Akamatsu T., Fukushima M., Nikaido T., Nakayama K., Usuda N., Kiyosawa K. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med: 2001; 344 732 738
87. Li Y., Nishihara E., Hirokawa M., Taniguchi E., Miyauchi A., Kakudo K. Distinct clinical, serological, and sonographic characteristics of hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab: 2010; 95 1309 1317
88. Kakudo K., Li Y., Hirokawa M., Ozaki T. Diagnosis of Hashimoto's thyroiditis and IgG4-related sclerosing disease. Pathol Int: 2011; 61 175 183
89. Dahlgren M., Khosroshahi A., Nielsen G. P., Deshpande V., Stone J. H. Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken): 2010; 62 1312 1318
90. Kemp E. H., Sandhu H. K., Watson P. F., Weetman A. P. Low frequency of pendrin autoantibodies detected using a radioligand binding assay in patients with autoimmune thyroid disease. J Clin Endocrinol Metab: 2013; 98 E309 E313
91. Brix T. H., Hegedus L., Weetman A. P., Kemp H. E. Pendrin and NIS antibodies are absent in healthy individuals and are rare in autoimmune thyroid disease: evidence from a Danish twin study. Clin Endocrinol (Oxf): 2014; 81 440 444
92. Ajjan R. A., Kemp E. H., Waterman E. A., Watson P. F., Endo T., Onaya T., Weetman A. P. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease. J Clin Endocrinol Metab: 2000; 85 2020 2027
93. Ajjan R. A., Findlay C., Metcalfe R. A., Watson P. F., Crisp M., Ludgate M., Weetman A. P. The modulation of the human sodium iodide symporter activity by Graves' disease sera. J Clin Endocrinol Metab: 1998; 83 1217 1221
94. McLachlan S. M., Rapoport B. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid: 2013; 23 14 24
95. Kamath C., Young S., Kabelis K., Sanders J., Adlan M. A., Furmaniak J., Rees Smith B., Premawardhana L. D. Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto's who developed Graves' disease and pretibial myxoedema. Clin Endocrinol (Oxf): 2012; 77 465 470
96. Lumachi F., Basso S. M., Orlando R. Cytokines thyroid diseases and thyroid cancer. Cytokine: 2010; 50 229 233
97. Ajjan R. A., Weetman A. P. Cytokines in thyroid autoimmunity. Autoimmunity: 2003; 36 351 359
98. Bettelli E., Korn T., Kuchroo V. K. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol: 2007; 19 652 657
99. Pan H. F., Li X. P., Zheng S. G., Ye D. Q. Emerging role of interleukin-22 in autoimmune diseases. Cytokine Growth Factor Rev: 2013; 24 51 57
100. Trifari S., Kaplan C. D., Tran E. H., Crellin N. K., Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol: 2009; 10 864 871
101. Figueroa-Vega N., Alfonso-Perez M., Benedicto I., Sanchez-Madrid F., Gonzalez-Amaro R., Marazuela M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab: 2010; 95 953 962
102. Bai X., Sun J., Wang W., Shan Z., Zheng H., Li Y., Zhao Y., Gong M., Teng W. Increased differentiation of Th22 cells in Hashimoto's thyroiditis. Endocr J: 2014
103. Song R. H., Yu Z. Y., Qin Q., Wang X., Muhali F. S., Shi L. F., Jiang W. J., Xiao L., Li D. F., Zhang J. A. Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis. Int J Clin Exp Pathol: 2014; 7 4024 4031
104. Ruggeri R. M., Saitta S., Cristani M., Giovinazzo S., Tigano V., Trimarchi F., Benvenga S., Gangemi S. Serum interleukin-23 (IL-23) is increased in Hashimoto's thyroiditis. Endocr J: 2014; 61 359 363
105. Ruffilli I., Ferrari S. M., Colaci M., Ferri C., Fallahi P., Antonelli A. IP-10 in autoimmune thyroid disease. Horm Metab Res: 2014; 46 597 602
106. Rebuffat S. A., Kammoun-Krichen M., Charfeddine I., Ayadi H., Bougacha-Elleuch N., Peraldi-Roux S. IL-1beta and TSH disturb thyroid epithelium integrity in autoimmune thyroid diseases. Immunobiology: 2013; 218 285 291
107. Kono H., Rock K. L. How dying cells alert the immune system to danger. Nat Rev Immunol: 2008; 8 279 289
108. Ishii K. J., Suzuki K., Coban C., Takeshita F., Itoh Y., Matoba H., Kohn L. D., Klinman D. M. Genomic DNA released by dying cells induces the maturation of APCs. J Immunol: 2001; 167 2602 2607
109. Kawashima A., Tanigawa K., Akama T., Wu H., Sue M., Yoshihara A., Ishido Y., Kobiyama K., Takeshita F., Ishii K. J., Hirano H., Kimura H., Sakai T., Ishii N., Suzuki K. Fragments of genomic DNA released by injured cells activate innate immunity and suppress endocrine function in the thyroid. Endocrinology: 2011; 152 1702 1712
110. Xiao C., Rajewsky K. MicroRNA control in the immune system: basic principles. Cell: 2009; 136 26 36
111. Bernecker C., Lenz L., Ostapczuk M. S., Schinner S., Willenberg H., Ehlers M., Vordenbaumen S., Feldkamp J., Schott M. MicroRNAs miR-146a1, miR-155-2, and miR-200a1 are regulated in autoimmune thyroid diseases. Thyroid: 2012; 22 1294 1295
112. Yamada H., Itoh M., Hiratsuka I., Hashimoto S. Circulating microRNAs in autoimmune thyroid diseases. Clin Endocrinol (Oxf): 2014; 81 276 281